USPTO serial 50083285
OPEONGO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with OPEONGO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Coral Gables, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roy D. Gross
Roy D. Gross The Roy Gross Law Firm, LLC19 Old Kings Hwy SSuite 200Darien, CT 06820Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of: extracellular matrix diseases, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, regeneration disorders and cancer; Antibodies for medical purposes; Therapeutic antibodies for the treatment of: extracellular matrix diseases, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, regeneration disorders and cancer | ACTIVE | — |
| 042 | Drug discovery services; Biochemical analysis services in the field of drug discovery; Biochemical analysis services in the field of medical diagnosis of disease; Biochemical analysis services in the field of drug target discovery; Pharmaceutical drug development services; Drug discovery services for: modulation of the extracellular matrix, prevention and treatment of fibrotic diseases, treating inflammatory diseases, treating age-related diseases, treating degenerative diseases, treating tissue repair, treating regeneration disorders, and chemotherapy; Scientific research for medical purposes in the area of fibrosis, cancerous diseases, modulation of the extracellular matrix, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, tissue repair, regeneration disorders; Biomedical research in the field of the extra cellular matrix and fibrosis; providing online non-downloadable software for modeling the extracellular matrix for use in drug and target discovery; providing online non-downloadable software for drug discovery in the field of: fibrosis, cancerous diseases, modulation of the extracellular matrix, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, tissue repair, and regeneration disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 1, 2026 | NWAP | NEW APPLICATION ENTERED | — |